Write-up: Information has been received from a physician concerning a female patient in her 70''s who in 2007 was vaccinated with a 0.65 ml dose of Zostavax. Subsequently "recently" in 2007, the patient developed a zoster-like rash and alot of pain all over. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. There was no product quality complaint involved. The physician considered the patient''s experiences to be disabling. Additional information has been requested.